Doris_huan 2019-05-13 10:39 IP：重慶
◆◆
簡(jiǎn)介：藥智人才是最專業(yè)的醫(yī)藥產(chǎn)業(yè)招聘平臺(tái)，與許多醫(yī)藥行業(yè)的知名企業(yè)都有合作，職位種類豐富，崗位更專業(yè)~ 賺取賞金規(guī)則（活動(dòng)時(shí)間：5月13日-5月17日）： 1.免費(fèi)注冊(cè)/登錄藥智人才（https://job.yaozh.com/），上傳簡(jiǎn)歷： 簡(jiǎn)歷完善度≥80 可獲得50元賞金； 2.簡(jiǎn)歷完成后，并截圖藥智人才簡(jiǎn)歷板塊的完善度提交審核，并且備注藥智人才的用戶名/注冊(cè)手機(jī)信息； 3.審核通過后，賞金會(huì)在3個(gè)工作日內(nèi)審核并發(fā)放，如提交后有刪除簡(jiǎn)歷的行為，視為作弊處理，對(duì)應(yīng)賞金將會(huì)被凍結(jié)不予提現(xiàn)。 4.特別福利：簡(jiǎn)歷完善后既有機(jī)會(huì)直接內(nèi)推給名企噢~ 溫馨提示： 1.如果疑問可以聯(lián)系客服QQ：3413833812 2.一經(jīng)發(fā)現(xiàn)求職者在上傳簡(jiǎn)歷期間有作弊等行為，藥智人才將取消其賞金并凍結(jié)該筆提現(xiàn)。 3.在法律允許的范圍內(nèi)，本活動(dòng)一切解釋權(quán)歸藥智人才 下期活動(dòng)預(yù)告 活動(dòng)日期：5月20-5月24日 賞金金額：更多賺取賞金細(xì)則5月20日揭曉噢~   [更多]
懸賞：
懸賞
￥500.00
已托管
載入中...
Doris_huan 2019-05-05 14:31 IP：重慶
◆◆
藥智人才是最專業(yè)的醫(yī)藥產(chǎn)業(yè)招聘平臺(tái)，與許多醫(yī)藥行業(yè)的知名企業(yè)都有合作，職位種類豐富，崗位更專業(yè)~ 賺取賞金規(guī)則： 1.免費(fèi)注冊(cè)/登錄藥智人才（https://job.yaozh.com/），上傳簡(jiǎn)歷： 簡(jiǎn)歷完善度≥80 可獲得10元賞金； 2.邀請(qǐng)朋友上傳簡(jiǎn)歷（無上限） 朋友上傳簡(jiǎn)歷完善度≥80 最高可獲得10000元賞金； 3.簡(jiǎn)歷完成后，并截圖藥智人才簡(jiǎn)歷板塊的完善度提交審核，并且備注藥智人才的用戶名/注冊(cè)手機(jī)信息； 4.審核通過后，賞金會(huì)在3個(gè)工作日內(nèi)審核，如提交后有刪除簡(jiǎn)歷的行為，視為作弊處理,對(duì)應(yīng)賞金將會(huì)被凍結(jié)不予提現(xiàn)。 5.特別福利：簡(jiǎn)歷完善后既有機(jī)會(huì)直接內(nèi)推給名企噢~ 溫馨提示： 1.如果疑問可以聯(lián)系客服QQ：3413833812 2.一經(jīng)發(fā)現(xiàn)求職者在上傳簡(jiǎn)歷期間有作弊等行為，藥智人才將取消其賞金。 3.在法律允許的范圍內(nèi)，本活動(dòng)一切解釋權(quán)歸藥智人才   [更多]
懸賞
￥800.00
已托管
載入中...
Like2291 2019-04-28 15:40 IP：重慶
◆◆
1.丙氨酰谷氨酰胺及其注射液的研究開發(fā) 2.A prospective multicentre study on the treatment of cardiovascular risk factors and claudication symptoms in patients with peripheral artery disease (the IDOMENEO study). Cimminiello C, Arpaia G, Polo Friz H, Boracchi P, Marano G, Spezzigu G, Visonà A. Vasa. 2015 Sep;44(5):371-9. doi: 10.1024/0301-1526/a000456. 3.2013 International Conference on Materials Engineering, ICMEN 2013 4.Orientation of substitution in the aromatic series. XVIII. Sulfonation of phenol by chlorosulfonic acid in solvents 5.Mechanism of reaction of chlorosulfonic acid with some aromatic compounds 6.Arzneimittelforschung. 1982;32(3):248-51. In vitro--in vivo correlation, a time scaling problem? Basic considerations on in vitro dissolution testing. 7.Oral treatment with the Crataegus special extract WS 1442 inhibits cardiac hypertrophy in rats with DOCA-salt or aortic banding induced hypertension   [更多]
懸賞
￥70.00
已托管
載入中...
Like2291 2019-04-28 11:59 IP：重慶
◆◆
1.Nakashima M, Morita J, Aizawa K. Pharamacokinetics and safety of tebipenem pivoxil fine granules, an oral carbapenem antibiotic, in healthy male volunteers. Jpn J Chemother. 2009;57(S–1):90–94 2.Baba S, Yamanaka N, Suzuki K, et al. Clinical efficacy, safety and PK-PD analysis of tebipenem pivoxil in a phase II clinical trial in otolaryngological infections. Jpn J Antibiot. 2009;62:155–177 3.Sunakawa K. Pharmacological properties and clinical performance of the novel oral carbapenem antimicrobial drug, “Tebipenem pivoxil” (Orapenem fine granules 10% for pediatric use). Jpn J Chemother. 2009;57:279–294 4.Yamanaka N, Furukawa M, Furuya, et al. Clinical efficacy of tebipenem pivoxil (ME1211), a novel oral carbapenem, in otolaryngological infections, a Phase II clinical trial (1). 45th Intersci Conf Antimicrob Agents Chemother (ICAAC) 2005; Abstract L-577 5.Iwata S, Ouchi K, Iwata N, et al. An open clinical study of tebipenem pivoxil in children with bacterial pneumonia. Jpn J Chemother. 2009;57(S–1):137–150   [更多]
懸賞
￥50.00
已托管
載入中...
pengjunpjhk 2019-04-22 10:59 IP：上海
◆◆
1、規(guī)模較小，生產(chǎn)許可證、GMP有效期內(nèi)，可正常生產(chǎn) 2、固體制劑（片劑、膠囊） 3、地區(qū)：華東六省、海南均可 4、中介勿擾   [更多]
懸賞
￥400.00
已托管
載入中...
ahasic 2019-04-16 11:00 IP：上海
◆◆
求購(gòu)“Fluorodopa (18F) (prepared by nucleophilic substitution) injection”《 EP9.7 》的藥典標(biāo)準(zhǔn)一份和親核取代法制備的“Radiopharmaceutical Preparations: Fluorodopa (18F) Injection”《 BP2019 》的藥典標(biāo)準(zhǔn)一份.   [更多]
懸賞
￥60.00
已托管
載入中...
Like2291 2019-04-16 10:07 IP：重慶
◆◆
1、Atropine and scopolamine premedication – Pharmacological aspects and present use in Finland 2、Identification and purity test of heparin by NMR - a summary of two years' experience at the Medical Products Agency By: McEwen I; Amini A; Olofsson I M 3、Atti della Accademia Nazionale dei Lincei, Classe di Scienze Fisiche, Matematiche e Naturali, Rendiconti 4、49-12 Metabolic Fate of Triethylenetetramine dihydrochloride (Trientine hydrochloride, TJA-250) 1. Absorption, Distribution and Excretion in Rats after Single … S Takeda, E Ono, Y Matsuzaki… - Oyo Yakuri …, 1995 - [Sendai, Japan: Oyo Yakuri … 5、49-13 Metabolic Fate of Triethylenetetramine dihydrochloride (Trientine hydrochloride, TJA-250) 2. Metabolism study in Rats Using 14C-TJA 250 S Takeda, E Ono, Y Wakui… - Oyo Yakuri …, 1995 - [Sendai, Japan: Oyo Yakuri …   [更多]
懸賞
￥50.00
已托管
載入中...
zy15310303705 2019-04-08 16:05 IP：重慶
◆◆
1. （7）G G, Shapiro ，Effects of albuterol and procaterol on exercise-induced asthma，Annals of allergy 65(4):273-6 . November 1990. 2. G G, Shapiro ，Effects of albuterol and procaterol on exercise-induced asthma，Annals of allergy 65(4):273-6 . November 1990. 3. 1.NAFLD in Asia—as common and important as in the West 4. Fundamentals of the chemotherapy of trichomoniasis and amebiasis with ornidazole 5. Atropine reduces experimental myopia and eye enlargement via a nonaccommodative mechanism 6. [1] Cheesman EH, Blanchette MA, Ganey MV, Maheu LI, Miller SJ, Watson AD. Technetium-99m ECD: ester-derivatizeddiamine-dithiolTc complexesforimaging brain perfusion [Abstract].J Nucl Med, 1988, 29:788. 7. [2] Demonceau G, Leveille J, De Roo M et al. Comparison of Tc-99m-ECD and Tc-99m-HMPAO: First human resulte[Abstract]. J Nucl Med, 1988, 29(5): 747. 8. standards of medical care in diabetic peripheral neuropathy 9. 2017年中藥飲片行業(yè)發(fā)展藍(lán)皮書   [更多]
懸賞
￥90.00
已托管
載入中...
<1...3637383940...65>
發(fā)布需求,坐等藥智客上門
  • 㒂安全可靠，先驗(yàn)收再正式付款
  • 㕞性價(jià)比超高，節(jié)省一半費(fèi)用
  • 㕊80%的需求得到了圓滿解決
立即發(fā)布需求

推薦任務(wù)